ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 633271 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 633271; 2) Community: the network communities that were significantly associated with the response to NSC 633271; 3) Molecule: the relationships between components within communities and NSC 633271; 4) MDR: the compounds that were significantly associated with the NSC 633271.

NSC Compound Enrichment Correlation
NSC 22709 v-Triazolo[4,5-d]pyrimidin-7-ol 0.0378615809326463 0.27788378
NSC 321240 Null 0.0378615809326463 0.089486402
NSC 328477 3'-Chloro-3-nitro-o-salicylotoluidide 0.0378615809326463 0.29924717
NSC 335995 Null 0.0378615809326463 0.073917321
NSC 339137 PHYSALOLACTONE 0.0378615809326463 0.22122928
NSC 354974 Acetamide, N-(5,6,7,9-tetrahydro-2,3-dihydroxy-1,10-dimethoxy-9-oxobenzo[a]heptalen-7-yl)-, (S)- 0.0378615809326463 0.31125937
NSC 371777 Null 0.0378615809326463 0.17870786
NSC 42972 Null 0.0378615809326463 0.3896352
NSC 55236 Null 0.0378615809326463 0.40364183
NSC 603578 Platinum, tetrachloro[dimethylsilylenebis(methanamine)]-, (OC-6-22) 0.0378615809326463 0.19593533
Total:75  Current:57    [First] [Prev] [Next] [Last]